Apoptosis and cell-cycle regulatory pathways

Apoptosis and cell-cycle regulatory pathways encompass the complex network of signaling cascades that govern programmed cell death and the progression of a cell through its division cycle. These pathways are fundamental to maintaining cellular homeostasis, ensuring that damaged or unnecessary cells are eliminated and that cell division occurs only under appropriate conditions (NIH, 2023). In many diseases, particularly cancer, these pathways are frequently dysregulated; for instance, overactive cell-cycle drivers or the evasion of apoptosis allow for uncontrolled tumor growth and survival (PubMed, 2022). Key components include cyclin-dependent kinases (CDKs) that drive the cell cycle and the BCL-2 family of proteins that regulate the mitochondrial pathway of apoptosis (StatPearls, 2024). Therapeutic strategies often focus on restoring these control mechanisms, such as using CDK4/6 inhibitors to induce cell-cycle arrest or BCL-2 inhibitors to trigger apoptosis in malignant cells. Because these pathways are also active in healthy tissues, targeting them requires careful management of toxicities like myelosuppression and gastrointestinal distress (Nature Reviews Drug Discovery, 2021).

Other names

Programmed cell death pathwaysCell cycle control mechanismsCell cycle and apoptosis signaling cascades

Pharmacological intervention in these pathways involves the inhibition of proteins that prevent apoptosis (e.g., BCL-2, BCL-XL) or the inhibition of kinases that promote cell cycle progression (e.g., CDK4, CDK6), thereby restoring the cell's natural ability to undergo programmed death or enter a state of growth arrest (PubMed, 2023).